Unfortunately, investing is risky - companies can and do go bankrupt. But if you pick the right stock, you can make a lot more than 100%. For example, the Lifecome Biochemistry Co.,Ltd. (SZSE:002868) share price has soared 151% return in just a single year. It's also good to see the share price up 98% over the last quarter. This could be related to the recent financial results, released recently - you can catch up on the most recent data by reading our company report. And shareholders have also done well over the long term, with an increase of 84% in the last three years.
In light of the stock dropping 9.2% in the past week, we want to investigate the longer term story, and see if fundamentals have been the driver of the company's positive one-year return.
Check out our latest analysis for Lifecome BiochemistryLtd
While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.
During the last year Lifecome BiochemistryLtd saw its earnings per share (EPS) drop below zero. While this may prove temporary, we'd consider it a negative, so we would not have expected to see the share price up. It may be that the company has done well on other metrics.
However the year on year revenue growth of 9.8% would help. Many businesses do go through a phase where they have to forgo some profits to drive business development, and sometimes its for the best.
The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).
![earnings-and-revenue-growth](https://usnewsfile.futunn.com/pic/0-14930350-0-689d41b1d17a9f147d58cf24b10cd0dc.png/big)
SZSE:002868 Earnings and Revenue Growth September 22nd 2022
Take a more thorough look at Lifecome BiochemistryLtd's financial health with this free report on its balance sheet.
A Different Perspective
It's nice to see that Lifecome BiochemistryLtd shareholders have received a total shareholder return of 151% over the last year. Since the one-year TSR is better than the five-year TSR (the latter coming in at 6% per year), it would seem that the stock's performance has improved in recent times. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Case in point: We've spotted 3 warning signs for Lifecome BiochemistryLtd you should be aware of.
If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on CN exchanges.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
不幸的是,投資是有風險的--公司可能而且確實會破產。但如果你選對了股票,你可以賺很多錢更多而不是100%。例如,生命美生物化學有限公司。[SZSE:002868]股價在短短一年內飆升了151%的回報率。上個季度股價上漲了98%,這也是件好事。這可能與最近發佈的財務業績有關-您可以通過閲讀我們的公司報告來了解最新的數據。從長期來看,股東的表現也很好,過去三年的漲幅為84%。
鑑於該公司股價在過去一週下跌了9.2%,我們希望調查更長期的情況,看看基本面因素是否是該公司一年來正回報的驅動因素。
查看我們對Lifecome BioChemical Ltd.的最新分析
雖然有效市場假説繼續被一些人傳授,但事實證明,市場是過度反應的動態系統,投資者並不總是理性的。通過比較每股收益(EPS)和股價隨時間的變化,我們可以感受到投資者對一家公司的態度隨着時間的推移發生了怎樣的變化。
在過去的一年裏,生命生命生物化學有限公司的每股收益(EPS)跌至零以下。雖然這可能被證明是暫時的,但我們會認為這是負面的,所以我們不會指望看到股價上漲。這可能是因為該公司在其他指標上表現良好。
然而,9.8%的同比收入增長將有所幫助。許多企業確實經歷了一個階段,他們不得不放棄一些利潤來推動業務發展,有時這是最好的。
下圖描述了收益和收入隨時間的變化(通過單擊圖像來揭示確切的價值)。
![earnings-and-revenue-growth](https://usnewsfile.futunn.com/pic/0-14930350-0-689d41b1d17a9f147d58cf24b10cd0dc.png/big)
深交所:2022年9月22日收益和收入增長002868
更全面地瞭解Lifecome BioChemical Ltd.的財務狀況免費報告其資產負債表。
不同的視角
很高興看到生命生物化學有限公司的股東在過去一年中獲得了151%的總股東回報。由於一年期的TSR好於五年期的TSR(後者的年收益率為6%),看起來該股的表現最近有所改善。鑑於股價勢頭依然強勁,仔細觀察這隻股票可能是值得的,以免錯過預期和機會。我發現,把股價作為衡量企業業績的長期指標是非常有趣的。但為了真正獲得洞察力,我們還需要考慮其他信息。一個恰當的例子:我們發現了Lifecome生化有限公司的3個警告標誌你應該意識到。
如果你像我一樣,你會的不想懷念這一切嗎?免費內部人士正在收購的成長型公司名單。
請注意,本文引用的市場回報反映了目前在CN交易所交易的股票的市場加權平均回報。
對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。